In re Tvl. International Institute of Bio Technology and Toxicology (GST AAR Tamilnadu)
The Advance Ruling application by Tvl. International Institute of Bio Technology and Toxicology (IIBAT) before the Tamil Nadu GST Authority has stirred significant debate regarding the place of supply for research and development (R&D) services provided to international clients. This case explores the applicability of Notification No. 04/2019-Integrated Tax and its implications on the GST treatment of services offered to sponsors located outside India. Here, we delve into the facts of the case, the GST provisions involved, and the implications of the ruling.
Case Background
Tvl. International Institute of Bio Technology and Toxicology specializes in conducting tests for clients, primarily involving research and development services related to agrochemicals. These services include analyzing test samples provided by international sponsors and delivering comprehensive test results and reports. The services fall under major categories such as Chemistry, Bio-efficacy, and Genetic Toxicology.
The applicant’s standard practice involves executing agreements with sponsors, who provide test items for analysis. These test items are consumed during the research and are not returned. Despite the services being consumed in India, the applicant issues invoices with 18% GST, believing the place of supply for such services is within India according to Section 13(3) of the IGST Act, 2017.
GST Provisions and Notifications
Section 13(3) of the IGST Act deals with the place of supply of services related to goods made available to the service provider. It stipulates that if the goods are made available by the recipient, the place of supply is where the services are actually performed. This provision has traditionally been interpreted to mean that if the test items are provided in India, the place of supply—and thus the GST liability—rests in India.
